Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays

Joëlle St-Pierre, Asher Shafrir, David T. Rubin

Open source

DOI
10.1080/17474124.2024.2412048
Published
2024-10-02
Container
Expert Review of Gastroenterology & Hepatology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17474124.2024.2412048,
  title = {Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays},
  author = {Joëlle St-Pierre and Asher Shafrir and David T. Rubin},
  year = {2024},
  journal = {Expert Review of Gastroenterology \& Hepatology},
  doi = {10.1080/17474124.2024.2412048},
  url = {https://doi.org/10.1080/17474124.2024.2412048}
}

RIS

TY  - JOUR
TI  - Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays
AU  - Joëlle St-Pierre
AU  - Asher Shafrir
AU  - David T. Rubin
PY  - 2024
JO  - Expert Review of Gastroenterology & Hepatology
DO  - 10.1080/17474124.2024.2412048
UR  - https://doi.org/10.1080/17474124.2024.2412048
ER  - 

APA

St-Pierre, J., Shafrir, A., & Rubin, D. T. (2024). Interrupting inflammatory bowel disease therapy: why, who, when and how to consider medication holidays. Expert Review of Gastroenterology & Hepatology. https://doi.org/10.1080/17474124.2024.2412048

Source records